Abstract:
At the same time, according to the results of the study, the antithrombin
potential of the blood increases with the progression of the disease, which can be
considered as a consequence of the anti-inflammatory effect of prolonged
immunosuppressive therapy and a decrease in the exudative component in the
evolution of the disease. The increase in antithrombin potential, according to our
data, does not include the activation of antithrombin III, which requires a study to
clarify the involvement of other natural anticoagulants in the formation of
increased antithrombin activity in the blood of RA patients
